Recent research from UC San Francisco reveals a concerning trend in California’s prostate cancer rates, with cases increasing by 6.7% annually between 2011 and 2021.
This rise coincides with the 2012 decision by the US Preventative Services Task Force to discontinue recommending routine PSA screenings, highlighting the delicate balance between avoiding over treatment of non-threatening tumors and ensuring early detection of aggressive cases.
While mortality rates initially declined and then plateaued, it does sort of established just how darn effective a simple act of screening even is to prevent future issues. That comes to the broader idea, getting the screening protocol right pays dividends in reducing healthcare costs and catching issues before they become a problem, especally in an aging population
Leave A Reply
Du musst angemeldet sein, um einen Kommentar abzugeben.
1 Kommentar
Recent research from UC San Francisco reveals a concerning trend in California’s prostate cancer rates, with cases increasing by 6.7% annually between 2011 and 2021.
This rise coincides with the 2012 decision by the US Preventative Services Task Force to discontinue recommending routine PSA screenings, highlighting the delicate balance between avoiding over treatment of non-threatening tumors and ensuring early detection of aggressive cases.
While mortality rates initially declined and then plateaued, it does sort of established just how darn effective a simple act of screening even is to prevent future issues. That comes to the broader idea, getting the screening protocol right pays dividends in reducing healthcare costs and catching issues before they become a problem, especally in an aging population